Variable Interest Entities - Summary of Operating Results (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Subsidiary or Equity Method Investee [Line Items]
Total revenues		$ 1,136,147	$ 653,445
Medical services expense		(972,827)	(566,208)
Other medical expenses		86,024	44,773
Income (loss) from operations		6,261	(743)
Net income (loss)		16,022	1,230
Medical Services Revenue
Subsidiary or Equity Method Investee [Line Items]
Total revenues		1,134,830	652,423
Direct Contracting Entities [Member]
Subsidiary or Equity Method Investee [Line Items]
Medical services expense		(257,477)	(248,351)
Other medical expenses	[1]	(15,744)	(12,644)
Income (loss) from operations		2,001	3,183
Net income (loss)	[2]	1,334	2,012
Direct Contracting Entities [Member] | Medical Services Revenue
Subsidiary or Equity Method Investee [Line Items]
Total revenues		$ 280,529	$ 267,713

[1] For the three months ended March 31, 2023 and 2022, includes physician incentive expenses of $9.7 million and $6.2 million, respectively.

[2] Included in Other income (expense) in the condensed consolidated statements of operations.